NOTCH1 is a well‐recognized prognostic marker, while KDM6A, as a histone demethylase involved in the demethylation of H3K27me1‐3 sites of super‐enhancers, may offer new insights into ACC treatment. The gene discussed is NOTCH1; the disease is adrenal cortex carcinoma.